Approval · Notice of Compliance 1427 · 2000
SYNERCID: Notice of Compliance 1427
Issued December 1, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1427
- Date
- December 1, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNERCID | 02241323 | Cancelled Post Market |
Medicinal ingredients
- QUINUPRISTIN 150 MG per VIAL
- DALFOPRISTIN 350 MG per VIAL